The MAPK pathway has been experimentally shown to regulate cyclin D1 in melanocytes and BRAFV600E superficial spreading melanoma [21], however, the connection between MAPK activity and cyclin D1 expression has not yet been established in ALM. Here, CCND1 is linked to superficial spreading melanoma.